Summary
How to manage the risks relating to commercial bribery in China? It is important.
Analysis
This article tells how Chinese government adopts measures to curb commercial bribery in the area of pharmaceuticals.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
